מדינה: ישראל
שפה: עברית
מקור: Ministry of Health
FOLLITROPIN ALFA
MERCK SERONO LTD
G03GA05
אבקה להכנת תמיסה לזריקה
FOLLITROPIN ALFA 5.5 MCG/DOSE
תוך-שרירי, תת-עורי
מרשם נדרש
MERCK SERONO S.A., SWITZERLAND
FOLLITROPIN ALFA
FOLLITROPIN ALFA
1) Gonal-F followed by chorionic gonadotrophin (hCG) is recommended for the stimulation of follicular development and ovulation in women with hypothalamic-pituitary dysfunction who present with either oligomenorrhoea or amenorrhoea. These women are classified as W.H.O group II patients and usually receive clomiphene citrate as primary therapy. They have evidence of endogenous oestrogen production and thus will either spontaneously menstruate or experience withdrawal bleeding after progestagen administration. Polycystic ovarian disease (PCOD) is part of the WHO II classification and is present in the majority of these patients. 2) Gonal-F is indicated for stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertillization (IVF) gamete intra-fallopian transfer (GIFT) and zogote intra-fallopian transfer (ZIFT). 3) Gonal-F is indicated with concomitant human chorionic gonadotrophin (HCG) therapy for the stimulation of sperma
2017-12-31